The DOI matches its Crossref record.
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia increases the deoxycytidine triphosphate (dCTP) level through the pentose phosphate pathway (PPP) via glucose metabolism and results in resistance to gemcitabine, a dCTP analog87.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [87]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Yoo, H. C., Park, S. J., Nam, M., Kang, J., Kim, K., Yeo, J. H., Kim, J.-K., Heo, Y., Lee, H. S., Lee, M. Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.020 · Cited by 449
Self-citationTargeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 431
Cell death in pancreatic cancer: from pathogenesis to therapy
Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00486-6 · Cited by 344
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Yang, Q., Wang, B., Zheng, Q., Li, H., Meng, X., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202207366 · Cited by 259
McDonald, P. C., Chafe, S. C., Brown, W. S., Saberi, S., Swayampakula, M., Venkateswaran, G., Nemirovsky, O., Gillespie, J. A., Karasinska, J. M., Kalloger, S. E., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.004 · Cited by 224
The roles of glucose metabolic reprogramming in chemo- and radio-resistance
Lin, J., Xia, L., Liang, J., Han, Y., Wang, H., Oyang, L., Tan, S., Tian, Y., Rao, S., Chen, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1214-z · Cited by 193
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer
Yu, M., Nguyen, N. D., Huang, Y., Lin, D., Fujimoto, T. N., Molkentine, J. M., Deorukhkar, A., Kang, Y., Lucas, F. A. S., Fernandes, C. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126915 · Cited by 176
Self-citationZeng, Z., Zhao, Y. B., Chen, Q., Zhu, S., Niu, Y., Zeng, Y., Hu, P., Chen, D., Xu, P., Chen, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01960-w · Cited by 178
Metabolic reprogramming, sensing, and cancer therapy
Mao, Y., Xia, Z., Xia, W., & Jiang, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115064 · Cited by 180
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Biancur, D. E., & Kimmelman, A. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.011 · Cited by 152
O-GlcNAc Transferase Links Glucose Metabolism to MAVS-Mediated Antiviral Innate Immunity
Li, T., Li, X., Attri, K. S., Liu, C., Li, L., Herring, L. E., Asara, J. M., Lei, Y. L., Singh, P. K., Gao, C., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.11.001 · Cited by 148
Self-citationAcquired resistance in cancer: towards targeted therapeutic strategies
Soragni, A., Knudsen, E. S., O’Connor, T. N., Tognon, C. E., Tyner, J. W., Gini, B., Kim, D., Bivona, T. G., Zang, X., Witkiewicz, A. K., et al. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00824-9 · Cited by 151
Self-citationThe biological underpinnings of therapeutic resistance in pancreatic cancerPreprint
Beatty, G. L., Werba, G., Lyssiotis, C. A., & Simeone, D. M. (2021) · Genes & Development · doi:10.1101/gad.348523.121 · Cited by 139
Self-citationEvolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma
Nie, M., Yao, K., Zhu, X., Chen, N., Xiao, N., Wang, Y., Peng, B., Yao, L., Li, P., Zhang, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26685-y · Cited by 130
Glucose Metabolism in Pancreatic Cancer
Liang, Y., Raj, P. S., Yao, W., & Ying, H. (2019) · Cancers · doi:10.3390/cancers11101460 · Cited by 128
Wallez, Y., Dunlop, C. R., Johnson, T. I., Koh, S., Fornari, C., Yates, J. W. T., Fernández, S. B. D. Q., Lau, A., Richards, F. M., & Jodrell, D. I. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0010 · Cited by 114
Lucarelli, G. T., Rutigliano, M., Loizzo, D., di Meo, N. A., Lasorsa, F. M., Mastropasqua, M. G., Maiorano, E., Bizzoca, C., Vincenti, L., Battaglia, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213968 · Cited by 112
Nelson, J. K., Thin, M. Z., Evan, T., Howell, S. A., Wu, M., Almeida, B., Legrave, N. M., Koenis, D. S., Koifman, G., Sugimoto, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29684-9 · Cited by 114
Yamada, K. J., Heim, C. E., Xi, X., Attri, K. S., Wang, D., Zhang, W., Singh, P. K., Bronich, T. K., & Kielian, T. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008354 · Cited by 95
Self-citationGSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer
Pecoraro, C., Faggion, B., Balboni, B., Carbone, D., Peters, G. J., Diana, P., Assaraf, Y. G., & Giovannetti, E. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100779 · Cited by 92
Li, Z., Ge, Y., Dong, J., Wang, H., Zhao, T., Wang, X., Liu, J., Gao, S., Shi, L., Yang, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.12.249 · Cited by 74
Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer
Serkova, N. J., Glunde, K., Haney, C. R., Farhoud, M., Lille, A. D., Redente, E. F., Simberg, D., Westerly, D., Griffin, L. R., & Mason, R. P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0373 · Cited by 77
Self-citationSignaling Pathways Regulating Redox Balance in Cancer Metabolism
Santis, M. C. D., Porporato, P. E., Martini, M., & Morandi, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00126 · Cited by 77
Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
Zhang, J., Mao, S., Guo, Y., Wu, Y., Yao, X., & Huang, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20181826 · Cited by 69
Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
Yu, L., Wang, M., Yang, Y., Xu, F., Zhang, X., Xie, F., Gao, L., & Li, X. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008696 · Cited by 68
Li, M., Lu, Y., Li, Y., Tong, L., Gu, X., Meng, J., Zhu, Y., Wu, L., Feng, M., Tian, N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3776 · Cited by 68
Zhang, J., Song, J., Tang, S., Zhao, Y., Wang, L., Luo, Y., Tang, J., Ji, Y., Wang, X., Li, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112620 · Cited by 62
Li, M., Zhang, X., Lu, Y., Meng, S., Quan, H., Hou, P., Tong, P., Chai, D., Gao, X., Zheng, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2225-6 · Cited by 60
Sun, Y. P., Ren, D., Zhou, Y., Shen, J., Wu, H., Jin, X., Fan, P., Gao, Y., Wu, H., & Jin, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04118-4 · Cited by 56
Meyer, H., Wienke, A., & Surov, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217781 · Cited by 58
Forming cytoophidia prolongs the half-life of CTP synthase
Sun, Z., & Liu, J. (2019) · Cell Discovery · doi:10.1038/s41421-019-0098-6 · Cited by 51
Ricciardiello, F., Yang, G., Palorini, R., Li, Q., Giampà, M., Zhao, F., You, L., Ferla, B. L., Vitto, H. D., Guan, W., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1260-1 · Cited by 47
MUC1: An emerging target in cancer treatment and diagnosis
Qing, L., Li, Q., & Dong, Z. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2022.08.001 · Cited by 45
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00226-5 · Cited by 42
Zhang, L., Li, Y., Dai, Y., Wang, D., Wang, X., Cao, Y., Liu, W., & Tao, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-98381-2 · Cited by 38
Ahmad, I. M., Dafferner, A. J., O’Connell, K. A., Mehla, K., Britigan, B. E., Hollingsworth, M. A., & Abdalla, M. Y. (2021) · Cancers · doi:10.3390/cancers13092264 · Cited by 37
Self-citationKnowles, H. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-78003-z · Cited by 35
Shi, X., Wang, M., Zhang, Y., Guo, X., Liu, M., Zhou, Z., Zhao, Y., He, R., Gao, Y., Liu, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104352 · Cited by 34
Tiemin, P., Xiao, P., Qingfu, L., Wang, Y., Junlin, X., Zhefeng, H., Ming, Z., Desen, L., & Qinghui, M. (2020) · Oncogenesis · doi:10.1038/s41389-020-0207-2 · Cited by 32
Alterations of commensal microbiota are associated with pancreatic cancer
Chen, T., Li, X., Li, G., Liu, Y., Huang, X., Ma, W., Qian, C., Jie, G., Wang, S., Qin, Q., et al. (2023) · The International Journal of Biological Markers · doi:10.1177/03936155231166721 · Cited by 33
Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
Smigiel, J. M., Parameswaran, N., & Jackson, M. W. (2018) · Cancers · doi:10.3390/cancers10010014 · Cited by 31
Han, L., Jiang, J., Ma, Q., Wu, Z., & Wang, Z. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4363 · Cited by 31
Zhu, M. P., & Wang, S. (2021) · Small Science · doi:10.1002/smsc.202000056 · Cited by 31
Gaidano, V., Houshmand, M., Vitale, N., Carrà, G., Morotti, A., Tenace, V., Rapelli, S., Sainas, S., Pippione, A. C., Giorgis, M., et al. (2021) · Cancers · doi:10.3390/cancers13051003 · Cited by 31
Strapcova, S., Takáčová, M., Csáderová, L., Martinelli, P., Lukáčiková, Ľ., Gál, V., Kopáček, J., & Švastová, E. (2020) · Cancers · doi:10.3390/cancers12082005 · Cited by 30
Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells
Santos-Jiménez, J. D. L., Campos-Sandoval, J. A., Márquez-Torres, C., Urbano-Polo, N., Brøndegaard, D., Martín‐Rufián, M., Lobo, C., Peñalver, A., Gómez-García, M. C., Martín-Campos, J., et al. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00712-y · Cited by 28
Self-citationNovel NRF2 ‐activated cancer treatments utilizing synthetic lethality
Baird, L., Kensler, T. W., & Yamamoto, M. P. (2022) · IUBMB Life · doi:10.1002/iub.2680 · Cited by 26
Yang, S. S., Tang, W., Azizian, A., Gaedcke, J., Ohara, Y., Cawley, H., Hanna, N. N., Ghadimi, M. B., Lal, T., Sen, S., et al. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae025 · Cited by 25
MiR-205 mediated APC regulation contributes to pancreatic cancer cell proliferation
Qin, R.-F., Zhang, J., Huo, H., Yuan, Z.-J., & Xue, J.-D. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3775 · Cited by 23
Yoneda, A., Minomi, K., & Tamura, Y. (2021) · Cancer Science · doi:10.1111/cas.14976 · Cited by 24
Mesmar, F., Dai, B., Ibrahim, A. A., Hases, L., Jafferali, M. H., Augustine, J. J., DiLorenzo, S., Kang, Y., Zhao, Y., Wang, J., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2581 · Cited by 21
Self-citationMethotrexate-based PROTACs as DHFR-specific chemical probes
Rana, S., Dranchak, P. K., Dahlin, J. L., Lamy, L., Li, W., Oliphant, E. N., Shrimp, J. H., Rajacharya, G. H., Tharakan, R., Holland, D. O., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.09.014 · Cited by 20
Self-citationPossible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer
Yada, E., Kasajima, R., Niida, A., Imoto, S., Miyano, S., Miyagi, Y., Sasada, T., & Wada, S. (2021) · Biomedicines · doi:10.3390/biomedicines9101396 · Cited by 20
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
du Toit‐Thompson, T., Leck, L. Y. W., Gillson, J., Pavlakis, N., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115647 · Cited by 20
Hasselluhn, M. C., Schlösser, D., Versemann, L., Schmídt, G., Ulisse, M., Oschwald, J., Zhang, Z., Hamdan, F. H., Xiao, H., Kopp, W., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.10.026 · Cited by 20
Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy
Bhoopathi, P., Mannangatti, P., Das, S. K., Fisher, P. B., & Emdad, L. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.010 · Cited by 19
Won, E.-J., Park, H., Yoon, T., & Cho, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010137 · Cited by 17
Qing, L., Li, Q., Yang, Y., Xu, W., Wang, Y., Li, R., You, C., & Dong, Z. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23725 · Cited by 17
Dhar, D., Raina, K., Kant, R., Wempe, M. F., Serkova, N. J., Agarwal, C., & Agarwal, R. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz114 · Cited by 16
Self-citationQing, L., Li, Q., Yang, Y., Xu, W., & Dong, Z. (2022) · BMC Urology · doi:10.1186/s12894-022-01067-8 · Cited by 15
MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
Huang, T., Bi, Y., Cui, Z., Guan, J., & Huang, Y. (2020) · Bioengineered · doi:10.1080/21655979.2020.1791590 · Cited by 16
MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer
Fu, X., Tang, N., Xie, W., Mao, L., & Qiu, Y. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)30019-4 · Cited by 14
Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment
Zhang, J., Wang, Y., Wang, L., You, L., & Zhang, T. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002758 · Cited by 13
Moreno, P., Ohara, Y., Craig, A. J., Liu, H., Yang, S. S., Dorsey, T. H., Zhang, L., Panigrahi, G., Cawley, H., Azizian, A., et al. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae056 · Cited by 11
Phan, T. X., Nguyen, V. H., Buettner, R., Morales, C. J., Yang, L., Wong, P., Tsai, W., Salazar, M. D., Gil, Z., Diamond, D. J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60473 · Cited by 10
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
Ali, A. H., Chianese, U., Papulino, C., Toraldo, A., Abakar, M. E. A., Passaro, E., Cennamo, R., Gaudio, N. D., Altucci, L., & Benedetti, R. (2022) · Cancers · doi:10.3390/cancers14153799 · Cited by 10
Soliman, G. A., Shukla, S. K., Etekpo, A., Gunda, V., Steenson, S., Gautam, N., Alnouti, Y., & Singh, P. K. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa131 · Cited by 8
Self-citationDhar, D., Raina, K., Kumar, D., Wempe, M. F., Bagby, S. M., Pitts, T. M., Orlicky, D. J., Agarwal, C., Messersmith, W. A., & Agarwal, R. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23251 · Cited by 8
Shen, X., Chen, Y., Liu, M., Shi, J., Tang, Y., Yang, X., Xu, D., Yao, H., Lu, P., Sun, Y., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.05.047 · Cited by 8
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling
Formica, V., Riondino, S., Morelli, C., Guerriero, S., D’Amore, F., Grazia, A. D., Blanco, G. D. V., Sica, G. S., Arkenau, H., Monteleone, G., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02266-2 · Cited by 8
Important roles of Hif1a in maternal or adult BPA exposure induced pancreatic injuries
Liu, H., Zhou, Y., Li, Y., & Gong, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-38614-8 · Cited by 7
Li, Y., Wang, H., Chen, L., Gong, Y., Zheng, D., Li, F., Wu, C., He, Z., & Yu, C. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08061-6 · Cited by 6
Liao, Y., Huang, P.-Q., Pan, H., Gai, Y., Zhan, Y., Li, S., & Nie, H. (2024) · The FASEB Journal · doi:10.1096/fj.202302287rr · Cited by 5
Classification From Compressive Representations Of Data
Coppa, B., David, D., Héliot, R., & Michel, O. (2012) · HAL · doi:10.5281/zenodo.43132 · Cited by 4
Zhao, Y., Ou, C., Huang, H., Wang, Y., Shen, J., Li, Y., He, Q., Han, Z., Xie, Y., Zhong, T., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-2313 · Cited by 3
Lü, H., Xu, W., Wu, Y., Yang, W.-J., & Liu, S. (2023) · Journal of Dental Sciences · doi:10.1016/j.jds.2023.01.035 · Cited by 3
Gu, W., Mo, S., Wang, Y., Kawabata‐Iwakawa, R., Zhang, W., Yang, Z., Sun, C., Tsushima, Y., Xu, H., & Nakajima, T. (2022) · Cancers · doi:10.3390/cancers14071825 · Cited by 3
Use of oral squamous cell carcinoma: A discussion paper
Senevirathna, K., Jayawardana, N. U., Gamage, C. U., Perera, A. G. U., Jayasinghe, R. D., & Seneviratne, B. (2023) · International Health Trends and Perspectives · doi:10.32920/ihtp.v3i1.1676 · Cited by 3
Genome profiling of mismatch repair genes in eight types of tumors
Wang, S., Guan, G., Zou, C., Guo, Q., Cheng, W., Shen, S., Fang, D., Wu, A., Li, G., & Zhu, C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1922160 · Cited by 2
Systemic Metabolomic Changes Associated with Chemotherapy: Role in Personalized Therapy
Kalita, B., Barik, G. K., Sharma, T., Taunk, K., Bhavsar, P. P., Santra, M. K., & Rapole, S. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch24 · Cited by 2
Combination Therapies for the Management of Cancer Immunotherapy
Chenchula, S., Anitha, K., Posinasetty, B., Bhatt, S., Mishra, N., Sharma, N., & Chandran, P. (2024) · Springer eBooks · doi:10.1007/978-981-97-7022-9_5 · Cited by 1
Li, X., Liu, L., Luo, L., Deng, M., Jiang, Y., Ren, W., & Qian, H. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113185 · Cited by 1
Ansari, A. M., Sharma, N. K., Tripathi, K., Bhardwaj, G., Chauhan, R., Tonk, R. K., Shahwan, M. J., Tuli, H. S., & Chauhan, A. P. S. (2025) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2025.204012 · Cited by 1
Tumor metabolic reprogramming in therapeutic resistance
Siegel, P. M., & Ursini‐Siegel, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00005-x · Cited by 1
Management of Primary Pancreatic Cancer
Pitiyarachchi, O., Kokkinos, J., Sharbeen, G., Phillips, P. A., Gandy, R. C., Haghighi, K. S., Moses, D. A., Thompson, S. R., Borbasi, J., Strutt, R., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch20
Up-Regulation of Non-Homologous End-Joining by MUC1
Bessho, T. (2024) · Genes · doi:10.3390/genes15060808
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986352
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986337
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986331
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986334
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986349
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986355
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986343
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986346
Sharma, N., Bhushan, A., He, J., Kaushal, G., & Bhardwaj, V. (2020) · Figshare · doi:10.6084/m9.figshare.12986340
Mechanisms of Gemcitabine Resistance in Pancreatic Cancer
章, 靓. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162492
Cai, K., Chen, S., Ma, G., Wu, W., Wang, S., Quan, B., Jin, C., Wang, Y., He, Z., & Wang, T. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08958-w
Ouyang, W., Wang, J., Chen, J., Fang, Z., Wei, T., Qian, J., & Gui, S. (2026) · Translational research · doi:10.1016/j.trsl.2026.09.009
Metadata
- Authors
- Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., Illies, A. L., Gebregiworgis, T., Dai, B., Augustine, J. J., Murthy, D., Attri, K. S., Mashadova, O., Grandgenett, P. M., Powers, R., Ly, Q. P., Lazenby, A. J., Grem, J. L., Yu, F., Matés, J. M., Asara, J. M., Kim, J.-W., Hankins, J. H., Weekes, C., Hollingsworth, M. A., Serkova, N. J., Sasson, A. R., Fleming, J. B., Oliveto, J. M., Lyssiotis, C. A., Cantley, L. C., Berim, L., & Singh, P. K.
- Affiliations
- Nebraska Medical Center (US)
- Corresponding author
- Singh, Pankaj K.
- ORCID
- Shukla, Surendra K.
- Purohit, Vinee
- Mehla, Kamiya
- Gunda, Venugopal
- Chaika, Nina V.
- Vernucci, Enza
- King, Ryan J.
- Abrego, Jaime
- Dasgupta, Aneesha
- Gebregiworgis, Teklab
- Dai, Bingbing
- Murthy, Divya
- Attri, Kuldeep S.
- Mashadova, Oksana
- Grandgenett, Paul M.
- Powers, Robert
- Ly, Quan P.
- Grem, Jean L.
- Matés, José M.
- Asara, John M.
- Kim, Jung-whan
- Weekes, Colin
- Hollingsworth, Michael A.
- Serkova, Natalie J.
- Fleming, Jason B.
- Lyssiotis, Costas A.
- Cantley, Lewis C.
- Singh, Pankaj K.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 32
- Issue
- 3
- Pages
- 392
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2783642736
- Cited by
- 98
- References
- 0
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 8 · 2023: 11 · 2022: 11 · 2021: 18 · 2020: 22 · 2019: 13 · 2018: 6
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- MUC1, HIF-1α, signaling crosstalk, gemcitabine resistance, pancreatic cancer, glycolysis, de novo pyrimidine biosynthesis, chemoresistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
